PSA screening doesn't reduce prostate cancer death rate

Standard PSA testing for prostate cancer doesn’t reduce the numbers of men who die from the disease, a new study has discovered.

Even men who had a PSA examination every year were just as likely to die from prostate cancer as those who weren’t regularly screened.

In a study of 6,400 men, researchers from the Siteman Cancer Center at Washington University School of Medicine found that annual screening over six years detected more cancers, but didn’t lead to fewer deaths, than those who were screened only when their doctor advised it.

(Source: New England Journal of Medicine, 2009; March 18, published online: 10.1056/NEJMoa0810696).

Related WDDTY Content

PSA screening is 'over-diagnosing prostate cancer'

Modern screening techniques are responsible for over-diagnosing prostate cancer, and which has resulted in more than 1 million men being treated unnec...

Psa screening more likely to result in death

PSA (prostate specific antigen) screening may be unable to detect prostate cancer, some scientists believe. More men who were screened died from pros...

Prostate cancer

Q:My husband, who is 63, was told several months ago that he had prostate cancer. I am giving my husband various homeopathic remedies. We have been...

Prostate cancer: wait and see

The idea of "watchful waiting" as a method of dealing with prostate cancer has gained more ground following a study in Sweden, which has the world's f...

Cancer: Death rate drops 60 per cent if you have someone to talk to

Yet more evidence of a link between the body and mind comes in a new study of elderly people with severe depression.

Prostate cancer

The most common cancer in elderly men, prostate cancer depends on male hormones called androgens, particularly testosterone.